Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2012


Metabolomics in Drug Development and Discovery

18 Sep 2012 - 20 Sep 2012 - Boston, USA



Bookmark and Share


Metabolomics provide the ultimate answer to how genetic alterations, disease and environmental influences impact in vivo biology and drug action. That is why, increasingly, drug developers are embracing the benefits of using metabolomics to enhance all aspects of development, from lead discovery right through to post approval surveillance.
Uncovering new drug targets. Identifying safety & efficacy biomarkers. Using pharmaco-metabolomic data in clinical trial design.

Make sure you stay abreast of the last progress and start applying metabolomics to your pipeline.

Metabolomics in Drug Discovery & Development is the world’s only commercially focussed metabolomics meeting. Bringing together the industry leaders to debate what challenges still remain and what stages of drug development can benefit most.

What will you gain from attending?

  • You will improve your knowledge of current metabolomic techniques in target identification & validation
  • Get a detailed understanding of how metabolomics can be used to reduce costs & time and improve safety of your clinical development
  • Hear in-depth studies on how pharmaceutical companies and leading innovators are applying metabolomics to understand biological variability
  • Receive an update on how the FDA are preparing for the use of metabolomics and biomarker data in drug submissions
  • Learn which technologies and services are helping to analyze complex metabolomic data sets and discover new biomarkers


Further information
Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Gene Regulation in Brain May Explain Repetitive Behaviors in Rett Syndrome Patients
The research could be a key step in developing treatments to eliminate symptoms that drastically impair the quality of life in Rett patients.
Heart Arrhythmia Caused by Mosaic of Mutant Cells
Researchers have solved the genetic mystery of an infant suffering from heart arrhythmia.
Iron Nanoparticles Make Immune Cells Attack Cancer
Researchers accidentally discover that nanoparticles invented for anemia treatment can trigger the immune system’s ability to destroy tumor cells.
Crispr Toolbox Expanded By Protein
Researchers have shown a newly discovered CRISPR protein has two distinct RNA cutting activities.
Atmosphere Acidity Minimised to Preindustrial Levels
Sheet ice study shows acidic pollution of the atmosphere has now almost returned to preindustrial levels.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Culex Mosquitoes Do Not Transmit Zika
A study of the Culex species mosquito appears to show that the species does not transmit Zika virus.
Uncovering Water Bear Resilience
A protein identified in water bears can protect DNA of human cells from lethal doses of radiation damage.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!